Comparison of SOX-10, HMB-45, and Melan-A in Benign Melanocytic Lesions.

atypical junctional melanocytic hyperplasia benign melanocytic lesion immunohistochemical stains lentigo melanocytes

Journal

Clinical, cosmetic and investigational dermatology
ISSN: 1178-7015
Titre abrégé: Clin Cosmet Investig Dermatol
Pays: New Zealand
ID NLM: 101543449

Informations de publication

Date de publication:
2021
Historique:
received: 12 08 2021
accepted: 28 09 2021
entrez: 22 10 2021
pubmed: 23 10 2021
medline: 23 10 2021
Statut: epublish

Résumé

Different immunohistochemical stains are used in dermatopathology to stain melanocytes and diagnose benign and malignant melanocytic lesions. SOX-10, HMB-45, and Melan-A immunohistochemical stains were used to assess 32 biopsy specimens with a histologic diagnosis of lentigo. The total number of melanocytes stained with each immunohistochemical stain was counted and an average count was obtained from two readings. Analysis of the data revealed a significant difference in staining melanocytes between these three immunostains (p=0.0010, ANOVA). SOX-10 stained 0.195 more melanocytes than HMB-45 (p=0.0026). Similarly, Melan-A stained 0.195 more melanocytes than HMB-45 (p=0.0011). However, the difference between SOX-10 and Melan-A was not statistically significant (p=0.9810). SOX-10 and Melan-A immunostaining stain more melanocytes than HMB-45. No significant difference was noted between Melan-A and SOX-10.

Identifiants

pubmed: 34675577
doi: 10.2147/CCID.S333376
pii: 333376
pmc: PMC8502009
doi:

Types de publication

Journal Article

Langues

eng

Pagination

1419-1425

Informations de copyright

© 2021 Dass et al.

Déclaration de conflit d'intérêts

The authors report no conflicts of interest in this work.

Références

Am J Dermatopathol. 2009 May;31(3):305-8
pubmed: 19384076
J Cell Biol. 1998 Aug 10;142(3):827-35
pubmed: 9700169
J Clin Pathol. 2001 Mar;54(3):196-200
pubmed: 11253130
Arch Pathol Lab Med. 2011 Jul;135(7):853-9
pubmed: 21732774
J Am Acad Dermatol. 1995 May;32(5 Pt 1):689-707; quiz 708-9
pubmed: 7722012
Am J Dermatopathol. 2004 Oct;26(5):364-6
pubmed: 15365366
J Cutan Pathol. 2018 Apr;45(4):263-268
pubmed: 29377259
Am J Dermatopathol. 2013 Feb;35(1):56-63
pubmed: 22688397
Drugs Context. 2015 May 29;4:212281
pubmed: 26082796
Am J Dermatopathol. 2011 Aug;33(6):573-8
pubmed: 21697700
Australas J Dermatol. 2016 Aug;57(3):229-34
pubmed: 26832231
Am J Dermatopathol. 2003 Apr;25(2):93-9
pubmed: 12652189
Dermatol Surg. 2007 Feb;33(2):199-207
pubmed: 17300606
Mod Pathol. 2000 Aug;13(8):857-60
pubmed: 10955451
J Cutan Pathol. 2008 May;35(5):433-44
pubmed: 18399807
Appl Immunohistochem Mol Morphol. 2015 Feb;23(2):109-12
pubmed: 25356946
Arch Pathol Lab Med. 2018 Jul;142(7):815-828
pubmed: 29939777

Auteurs

Sabrina E Dass (SE)

Wayne State University School of Medicine, Detroit, MI, USA.

Taryn Huizenga (T)

Department of Dermatology, Wayne State University, Detroit, MI, USA.

Mehdi Farshchian (M)

Department of Dermatology, Wayne State University, Detroit, MI, USA.

Darius R Mehregan (DR)

Department of Dermatology, Wayne State University, Detroit, MI, USA.

Classifications MeSH